Searched for
NASAL COVID VACCINE
ET Business Reformer of the year: Mansukh Mandaviya - Building a bigger ‘Obamacare’ in IndiaMandaviya was given the critical health portfolio in July 2021 when the country was still reeling from the second Covid wave. He was promot...- Bharat Biotech's nasal Covid vaccine iNCOVACC launchedThe announcement regarding the launch of iNCOVACC on January 26 was made last week by the company’s chairman and managing director. The nas...
- On January 26, India's first COVID intranasal vaccination iNCOVACC will go on saleiNCOVACC, a brand-new domestic drug, has been introduced by Bharat Biotech to aid in the fight against COVID 19. The nasal Covid vaccine ha...
- A nose for wider booster vaccinationThe development of the first nasal Covid vaccine, along with others before it, is an affirmation of India's capacity to provide solutions t...
- How not to become China: Wastewater sampling — best strategy for a Covid-fatigued nationThe need of the hour is a dynamic, evidence-based approach, with involvement of public health experts and epidemiologists as guides, and to...
- Easy to use, effective & economical: Nasal Covid vaccines to be a game-changer, say scientistsResearchers believe mucosal vaccines may prevent even mild cases of illness and block transmission to other people.
- Easy to use, more effective and cheap, nasal Covid vaccines can be game changer: scientistsEarlier this month, Bharat Biotech announced that its iNCOVACC (BBV154),the world's first intranasal COVID-19 vaccine, has received approva...
- BBV154: What you need to know about Bharat Biotech's nasal Covid vaccineIt may produce local antibodies in the upper respiratory tract - which could provide the potential to reduce infection and transmission.
- No more jabs: Nasal Covid vaccines may be the future as they treat the infection right where it startsNasal vaccines are administered, as the name suggests, through the nose.
- The answer to stopping the coronavirus may be up the noseThe currently available Covid-19 vaccines are injected into people’s arm muscles and are highly capable at combating the virus once people ...
- DCGI allows Bharat Biotech to conduct phase-3 trials for Covid's intranasal booster doseThe trials of the Intranasal vaccine will take place at nine different sites of the country.
- Government panel recommends mixing Bharat Biotech's Covaxin and nasal vaccine in trialsThe subject expert committee (SEC) under India's drug regulator gave its go-ahead to Hyderabad-based Bharat Biotech to conduct the phase 2/...
- Nasal Covid vaccine prevents disease, transmission in animals: StudyThis new method is unlike the currently approved COVID-19 vaccines that require an injection.
- Bharat Bio seeks nod to conduct trials of nasal Covid vaccineBharat Biotech, which has developed India’s indigenous Covid-19 vaccine, Covaxin, has sought regulatory approval to start phase-1 and phase...
Load More
